Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy is associated with reduced incidence of … AK Taylor, TR Zembower, RB Nadler, MH Scheetz, JP Cashy, D Bowen, ... The Journal of urology 187 (4), 1275-1279, 2012 | 313 | 2012 |
Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy SM Trifilio, CL Bennett, PR Yarnold, JM McKoy, J Parada, J Mehta, ... Bone marrow transplantation 39 (7), 425-429, 2007 | 252 | 2007 |
Correlations of antibiotic use and carbapenem resistance in Enterobacteriaceae M McLaughlin, MR Advincula, M Malczynski, C Qi, M Bolon, MH Scheetz Antimicrobial agents and chemotherapy 57 (10), 5131-5133, 2013 | 207 | 2013 |
Effects on patient care caused by drug shortages: a survey M McLaughlin, D Kotis, K Thomson, M Harrison, G Fennessy, ... Journal of Managed Care Pharmacy 19 (9), 783-788, 2013 | 174 | 2013 |
Vancomycin area under the curve and acute kidney injury: a meta-analysis DM Aljefri, SN Avedissian, NJ Rhodes, MJ Postelnick, K Nguyen, ... Clinical Infectious Diseases 69 (11), 1881-1887, 2019 | 158 | 2019 |
The emperor’s new clothes: prospective observational evaluation of the association between initial vancomycin exposure and failure rates among adult hospitalized patients with … TP Lodise Jr, SL Rosenkranz, M Finnemeyer, S Evans, M Sims, ... Clinical Infectious Diseases 70 (8), 1536-1545, 2020 | 135 | 2020 |
In Vitro Activities of Various Antimicrobials Alone and in Combination with Tigecycline against Carbapenem-Intermediate or -Resistant Acinetobacter baumannii MH Scheetz, C Qi, JR Warren, MJ Postelnick, T Zembower, A Obias, ... Antimicrobial agents and chemotherapy 51 (5), 1621-1626, 2007 | 135 | 2007 |
Antimicrobial stewardship programs: methods of operation and suggested outcomes M Griffith, M Postelnick, M Scheetz Expert review of anti-infective therapy 10 (1), 63-73, 2012 | 117 | 2012 |
Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections JS Esterly, M Griffith, C Qi, M Malczynski, MJ Postelnick, MH Scheetz Antimicrobial agents and chemotherapy 55 (10), 4844-4849, 2011 | 113 | 2011 |
The effect of time to antifungal therapy on mortality in Candidemia associated septic shock GP Patel, D Simon, M Scheetz, CW Crank, T Lodise, N Patel American journal of therapeutics 16 (6), 508-511, 2009 | 111 | 2009 |
Increasing Incidence of Linezolid-Intermediate or -Resistant, Vancomycin-Resistant Enterococcus faecium Strains Parallels Increasing Linezolid Consumption MH Scheetz, SA Knechtel, M Malczynski, MJ Postelnick, C Qi Antimicrobial agents and chemotherapy 52 (6), 2256-2259, 2008 | 104 | 2008 |
Characterization of Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii Clinical Strains Collected from 2004 to 2007 C Qi, M Malczynski, M Parker, MH Scheetz Journal of clinical microbiology 46 (3), 1106-1109, 2008 | 104 | 2008 |
Evaluation of clinical outcomes in patients with bloodstream infections due to Gram-negative bacteria according to carbapenem MIC stratification JS Esterly, J Wagner, MM McLaughlin, MJ Postelnick, C Qi, MH Scheetz Antimicrobial agents and chemotherapy 56 (9), 4885-4890, 2012 | 99 | 2012 |
Quantifying the clinical virulence of Klebsiella pneumoniae producing carbapenemase Klebsiella pneumoniae with a Galleria mellonellamodel and a pilot study … MM McLaughlin, MR Advincula, M Malczynski, G Barajas, C Qi, ... BMC infectious diseases 14, 1-10, 2014 | 95 | 2014 |
Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19 MF Konig, AHJ Kim, MH Scheetz, ER Graef, JW Liew, J Simard, ... Annals of the rheumatic diseases 79 (10), 1386-1388, 2020 | 94 | 2020 |
Knowledge and attitudes of doctor of pharmacy students regarding the appropriate use of antimicrobials JA Justo, TP Gauthier, MH Scheetz, EB Chahine, PB Bookstaver, ... Clinical Infectious Diseases 59 (suppl_3), S162-S169, 2014 | 94 | 2014 |
Bacterial and clinical characteristics of health care-and community-acquired bloodstream infections due to Pseudomonas aeruginosa A Hattemer, A Hauser, M Diaz, M Scheetz, N Shah, JP Allen, ... Antimicrobial agents and chemotherapy 57 (8), 3969-3975, 2013 | 88 | 2013 |
A review of the clinical pharmacokinetics of polymyxin B SN Avedissian, J Liu, NJ Rhodes, A Lee, GM Pais, AR Hauser, ... Antibiotics 8 (1), 31, 2019 | 87 | 2019 |
Treatment outcomes with cefazolin versus oxacillin for deep-seated methicillin-susceptible Staphylococcus aureus bloodstream infections SN Rao, NJ Rhodes, BJ Lee, MH Scheetz, AP Hanson, J Segreti, ... Antimicrobial agents and chemotherapy 59 (9), 5232-5238, 2015 | 87 | 2015 |
Potential Impact of Vancomycin Pulmonary Distribution on Treatment Outcomes in Patients with Methicillin‐Resistant Staphylococcus aureus Pneumonia MH Scheetz, RG Wunderink, MJ Postelnick, GA Noskin Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 26 (4 …, 2006 | 85 | 2006 |